Loading clinical trials...
Loading clinical trials...
The investigators' goal is to develop neuroimaging biomarkers to predict response to treatment with methylphenidate, which then can be used in the development of novel pharmacological treatments for a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Johns Hopkins University
Collaborators
NCT06465641 · Kbg Syndrome, ADHD - Combined Type
NCT05631626 · ADHD, ADHD - Combined Type, and more
NCT04799886 · Attitude, ADHD - Combined Type, and more
NCT01727414 · ADHD - Inattentive Type, ADHD - Combined Type
NCT03335748 · ADHD, ADHD - Combined Type
Johns Hopkins School of Medicine
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions